Suchergebnisse - "Kim, Nam Joong"

PubPharm (32)

1

Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy

enthalten in: Cancer research and treatment | 2024

von Lee, C. | Choe, P. | Kang, C. | +6

2

Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea

enthalten in: Infection & chemotherapy | 2023

von Lee, M. | Park, W. | Kim, E. | +15

CommentIn: Infect Chemother. 2024 Mar;56(1):90-91. - PMID 38527775

3

Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea

enthalten in: Journal of Korean medical science | 2023

von Lee, E. | Kim, S. | Lee, S. | +7

4

Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals

enthalten in: Journal of medical virology | 2023

von Kang, C. | Kim, M. | Park, S. | +12

5

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19

enthalten in: Frontiers in immunology | 2023

von Lee, C. | Choe, P. | Kang, C. | +13

6

Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment

enthalten in: The oncologist | 2022

von Kim, J. | Chang, E. | Park, S. | +8

7

Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection

enthalten in: BMC research notes | 2022

von Oh, S. | Lee, J. | Jo, H. | +12

8

Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection

enthalten in: BMC Research Notes | 2022

von Oh, S. | Lee, J. | Jo, H. | +12

9

Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection

enthalten in: BMC Research Notes | 2022

von Oh, S. | Lee, J. | Jo, H. | +12

10

Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection

enthalten in: The Journal of infectious diseases | 2022

von Choe, P. | Hong, J. | Park, J. | +6